Argos Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Argos Corporation - overview
Established
1997
Location
Taunton, MA, US
Primary Industry
Medical Devices & Equipment
About
Based in the US, Argos Corporation specializes in manufacturing custom plastic tubing, filaments, and precision extrusions, primarily serving the medical, pharmaceutical, and industrial sectors. Founded in 1997 in Taunton, US, Argos Corporation focuses on the production of specialized plastic products. The company has not undergone any notable pivots or changes in business operations since its inception. It remains an independent entity without any known parent or subsidiary companies.
The company’s operations include a single deal noted in December 2025, when it was acquired by Aptyx, a portfolio company of TruArc Partners, with undisclosed financial terms. The founder's previous ventures are not documented in the available information. Argos Corporation specializes in the manufacturing of custom plastic tubing, filaments, and precision extrusions, catering primarily to the medical, pharmaceutical, and industrial sectors. The core product offerings include small-diameter custom tubing tailored to specific client needs, as well as heat shrinkable tubing for various applications across multiple industries.
These products are engineered to support the evolving demands of technology and innovation, addressing critical use cases in the production of medical devices and industrial applications. Argos Corporation's client base includes businesses that require high-quality, customized solutions, with markets spanning North America and potentially extending into select international regions. Operating on a business-to-business (B2B) model, Argos Corporation generates revenue through direct transactions with clients, often involving tailored agreements that include bulk purchasing arrangements based on specific project requirements. This structure ensures timely delivery and quality assurance in alignment with clients’ operational timelines.
Revenue is primarily derived from these direct contracts, particularly emphasizing flagship products such as medical tubing and heat shrinkable tubing. Pricing plans reflect the complexity and customization of the offerings, ensuring compliance with clients' technical specifications. In December 2025, Argos Corporation was acquired by Aptyx, with plans to further enhance its product offerings and expand market reach. Future strategies include the launch of new products designed for the medical and industrial sectors, with specific release dates yet to be announced.
The company aims to target new geographic regions for expansion, building on its existing North American presence and exploring opportunities in select international markets. The recent acquisition will support these initiatives, although detailed funding allocations have not been disclosed.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.argosco.com
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.